Cargando…

Fe Porphyrin-Based SOD Mimic and Redox-Active Compound, (OH)FeTnHex-2-PyP(4+), in a Rodent Ischemic Stroke (MCAO) Model: Efficacy and Pharmacokinetics as Compared to Its Mn Analogue, (H(2)O)MnTnHex-2-PyP(5+)

Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, (H(2)O)MnTnHex-2-PyP(5+) (MnHex) carrying long hexyl chains, is a lipophilic mimic of superoxide dismutase (SOD) and a redox-active drug candidate. MnHex crosses the blood–brain barrier, and improved neurologic outcome and decreased infarct s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Litao, Tovmasyan, Artak, Sheng, Huaxin, Xu, Bin, Sampaio, Romulo S., Reboucas, Julio S., Warner, David S., Batinic-Haberle, Ines, Spasojevic, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346179/ https://www.ncbi.nlm.nih.gov/pubmed/32492872 http://dx.doi.org/10.3390/antiox9060467

Ejemplares similares

Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+)()
por: Gauter-Fleckenstein, Benjamin, et al.
Publicado: (2014)

The SOD Mimic MnTnHex-2-PyP(5+) Reduces the Viability and Migration of 786-O Human Renal Cancer Cells
por: Costa, João G., et al.
Publicado: (2019)

MnTnHex-2-PyP(5+) Displays Anticancer Properties and Enhances Cisplatin Effects in Non-Small Cell Lung Cancer Cells
por: Soares, Rita B., et al.
Publicado: (2022)

Post-Irradiation Treatment with a Superoxide Dismutase Mimic, MnTnHex-2-PyP(5+), Mitigates Radiation Injury in the Lungs of Non-Human Primates after Whole-Thorax Exposure to Ionizing Radiation
por: Cline, John Mark, et al.
Publicado: (2018)

The manganese(III) porphyrin MnTnHex-2-PyP(5+) modulates intracellular ROS and breast cancer cell migration: Impact on doxorubicin-treated cells
por: Flórido, Ana, et al.
Publicado: (2018)

MnTnHex-2-PyP(5+), Coupled to Radiation, Suppresses Metastasis of 4T1 and MDA-MB-231 Breast Cancer via AKT/Snail/EMT Pathways
por: Shin, Sung-Won, et al.
Publicado: (2021)

A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP(5+), Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line
por: Chaiswing, Luksana, et al.
Publicado: (2022)

Photoinactivation of Yeast and Biofilm Communities of Candida albicans Mediated by ZnTnHex-2-PyP(4+) Porphyrin
por: Souza, Sueden O., et al.
Publicado: (2022)

CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP(5+)
por: Leu, David, et al.
Publicado: (2017)

Porphyrin‐Based SOD Mimic MnTnBuOE‐2‐PyP(5+) Inhibits Mechanisms of Aortic Valve Remodeling in Human and Murine Models of Aortic Valve Sclerosis
por: Anselmo, Wanda, et al.
Publicado: (2018)

A novel redox regulator, MnTnBuOE-2-PyP(5+), enhances normal hematopoietic stem/progenitor cell function
por: Zhao, Y., et al.
Publicado: (2017)

Nanoformulation of the superoxide dismutase mimic, MnTnBuOE-2-PyP(5+), prevents its acute hypotensive response
por: Schlichte, Sarah L., et al.
Publicado: (2020)

Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum()
por: Archambeau, John O., et al.
Publicado: (2013)

Antioxidant Effect of MnTE-2-PyP on Lung in Asthma Mice Model
por: Terziev, Lyudmil, et al.
Publicado: (2012)

Mn(III) Porphyrin, MnTnBuOE-2-PyP(5+), Commonly Known as a Mimic of Superoxide Dismutase Enzyme, Protects Cardiomyocytes from Hypoxia/Reoxygenation Induced Injury via Reducing Oxidative Stress
por: Sharma, Sudha, et al.
Publicado: (2023)

The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation
por: Oberley-Deegan, Rebecca E., et al.
Publicado: (2012)

Intracarotid Infusion of Redox-Active Manganese Porphyrin, MnTnBuOE-2-PyP(5+), following Reperfusion Improves Long-Term, 28-Day Post-Stroke Outcomes in Rats
por: Li, Xuan, et al.
Publicado: (2023)

MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer
por: Patel, Anery, et al.
Publicado: (2019)

Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment
por: McElroy, Taylor, et al.
Publicado: (2020)

MnTE-2-PyP protects fibroblast mitochondria from hyperglycemia and radiation exposure
por: Chatterjee, Arpita, et al.
Publicado: (2022)

The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP(5+), Impairs the Migration and Invasion of Non-Small Cell Lung Cancer Cells, Either Alone or Combined with Cisplatin
por: Soares, Rita B., et al.
Publicado: (2023)

MnTnBuOE-2-PyP protects normal colorectal fibroblasts from radiation damage and simultaneously enhances radio/chemotherapeutic killing of colorectal cancer cells
por: Kosmacek, Elizabeth A., et al.
Publicado: (2016)

Redox-Active Drug, MnTE-2-PyP(5+), Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function
por: Barbosa, Andrezza M., et al.
Publicado: (2020)

The Metalloporphyrin Antioxidant, MnTE-2-PyP, Inhibits Th2 Cell Immune Responses in an Asthma Model
por: Jungsuwadee, Paiboon, et al.
Publicado: (2012)

MnTE-2-PyP Suppresses Prostate Cancer Cell Growth via H(2)O(2) Production
por: Zhu, Yuxiang, et al.
Publicado: (2020)

The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues
por: Shrishrimal, Shashank, et al.
Publicado: (2017)

Superoxide Dismutase Mimic, MnTE-2-PyP Enhances Rectal Anastomotic Strength in Rats after Preoperative Chemoradiotherapy
por: Yang, Yu, et al.
Publicado: (2020)

MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses
por: Chatterjee, Arpita, et al.
Publicado: (2020)

MnTE-2-PyP Attenuates TGF-β-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2/3 Signaling Pathway
por: Yang, Yu, et al.
Publicado: (2019)

An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H(2)O(2)-driven pathways
por: Batinic-Haberle, Ines, et al.
Publicado: (2015)

Corrigendum to ‘An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H(2)O(2)-driven pathways’ [Redox Biology 5C (2015) 43–65]
por: Batinic-Haberle, Ines, et al.
Publicado: (2015)

H(2)O(2)-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways
por: Batinic-Haberle, Ines, et al.
Publicado: (2021)

Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes
por: Hasan, Bader, et al.
Publicado: (2021)

Design, Mechanism of Action, Bioavailability and Therapeutic Effects of Mn Porphyrin-Based Redox Modulators
por: Tovmasyan, Artak, et al.
Publicado: (2013)

Rational Design of Superoxide Dismutase (SOD) Mimics: The Evaluation of the Therapeutic Potential of New Cationic Mn Porphyrins with Linear and Cyclic Substituents
por: Tovmasyan, Artak, et al.
Publicado: (2014)

Late administration of Mn porphyrin-based SOD mimic enhances diabetic complications()
por: Ali, Dana K., et al.
Publicado: (2013)

Synthesis and Characterization of a Linear [Mn(3)(O(2)CMe)(4)(py)(8)](2+) Complex
por: Moushi, Eleni E., et al.
Publicado: (2010)

Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT
por: Ren, Chao, et al.
Publicado: (2021)

The crystal structures of iron and cobalt pyridine (py)–sulfates, [Fe(SO(4))(py)(4)](n) and [Co(3)(SO(4))(3)(py)(11)](n)
por: Pham, Duyen N. K., et al.
Publicado: (2018)

SciPy and NumPy
por: Bressert, Eli
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fqbs58j6uqkmfm4fl645s7c5r7